Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 1 Sept 2022

Ronan N J, Einarsson G G, Deane J, Fouhy F, Rea M, Hill C, Shanahan F, Elborn J S, Ross R P, McCarthy M, Murphy D M, Eustace J A, Mm Tunney, Stanton C, Plant B J

Abstract excerpt

BACKGROUND: Cystic Fibrosis (CF) has prominent gastrointestinal and pancreatic manifestations. The aim of this study was to determine the effect of Cystic fibrosis transmembrane conductance regulator (CFTR) modulation on, gastrointestinal inflammation, pancreatic function and gut microbiota composition in people with cystic fibrosis (CF) and the G551D-CFTR mutation. METHODS: Fourteen adult patients with the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Inflammation

Share to Lactoferrin

Share to Leukocyte L1 Antigen Complex

Share to Microbiota

Share to Quinolones

Source

Identifiers

PMID: 35764510
DOI: 10.1016/j.jcf.2022.06.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.PMID 35764510Read ↗

Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal InflammationSemantic proximity Read ↗

Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axesSemantic proximity Read ↗

Cystic fibrosis and inflammatory bowel disease: parallels in gut physiology and microbiotaSemantic proximity Read ↗

The altered gut microbiota in adults with cystic fibrosis.Semantic proximity Read ↗

The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.Semantic proximity Read ↗

Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice on Regimens Preventing Intestinal ObstructionSemantic proximity Read ↗

Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.Semantic proximity Read ↗

Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional DysbiosisSemantic proximity Read ↗

Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis.Semantic proximity Read ↗

Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition.Semantic proximity Read ↗

Gut microbiota in adults with cystic fibrosis: Implications for the severity of the CFTR gene mutation and nutritional status.Semantic proximity Read ↗

Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.